Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants

Pediatrics

Volumn 107, Issue 1, 2001, Pages 78-85

  Pollak, Arnold ^a   Hayde, Michael ^a   Hayn, Marianne ^b   Herkner, Kurt ^a   Lombard, Kenneth A ^c   Lubec, Gert ^a   Weninger, Manfred ^a   Widness, John A ^d  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c Barbara Bush Children's Hospital   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Erythropoiesis; Erythropoietin treated infants; Intravenous; Iron supplementation; Very low birth weight infants

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; FERRIC HYDROXIDE SUCROSE; FERRITIN; FOLIC ACID; HEMOGLOBIN; IRON; IRON POLYMALTOSE; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; IRON ABSORPTION; MALE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

ADMINISTRATION, ORAL; ASCORBIC ACID; BLOOD CELL COUNT; DRUG THERAPY, COMBINATION; ERYTHROCYTE INDICES; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; ERYTHROPOIETIN; FERRIC COMPOUNDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INJECTIONS, INTRAVENOUS; IRON; MALONDIALDEHYDE; PROSPECTIVE STUDIES; TYROSINE;

EID: 0035186742     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.107.1.78     Document Type: Article

References (37)

1. Recombinant erythropoietin for the anemia of prematurity: Still a promise, not a panacea
2. Recombinant erythropoietin in treatment of the premature newborn
3. The role of erythropoietin in the anemia of prematurity
4. Factors related to transfusion in very low birth weight infants treated with erythropoietin
5. Recombinant human erythropoieitin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study
6. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants
7. Recombinant erythropoietin in anemia of prematurity: Five years later
8. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants
9. Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously
10. Iron metabolism and iron substitution during erythropoietin therapy
11. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin
12. The effect of erythropoietin on the transfusion requirements of preterm infants ≤750 grams: A randomized, double-blind, placebo-controlled study
13. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants
14. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuious infusion in total parenteral nutrition solution
15. Iron and infection
16. 58Fe in erythropoietin treated premature infants
17. Profiles of mean arterial blood pressure (MAP) for infants weighing 501-1500 grams
18. A simple and inexpensive method for plasma transferrin determination
19. Hydroxyl radical generation in oxygen-treated infants
20. Effect of supplementation of smoking men with plain or slow release ascorbic acid on lipoprotein
21. Reticulocyte maturity pattern analysis as a predictive marker of erythropoiesis in pediatrics: Pilot study for clinical application
22. Trace elements and foetal and early postnatal development
23. Blood sampling in very low birth infants receiving different levels of intensive care
24. Intravenous iron administration to very-low-birth-weight newborns receiving total and partial parenteral nutrition
25. The role of transferrin and ferritin in the fetal-maternal placenta unit
26. A multicenter randomized double-masked placebo-controlled trial of early erythropoietin and iron admistration to preterm infants
27. Postnatal changes in some red cell parameters
28. Normal blood values in the newborn period
29. Percentage hypochromic red cells and the response to intravenous iron therapy in anemic patients
30. Premature infants require additional folate and vitamin B-12 to reduce the severity of the anemia of prematurity
31. Oxygen radical disease in neonatology
32. Iron, plasma antioxidants, and the "oxygen radical disease of prematurity"
33. Development of the antioxidant defences in fetal life
34. The effect of exercise intensity on lipid peroxidation
35. The effect of low carotenoid diet on malondialdehyde-thiobarbituric acid (MDA-TBA) concentrations in women: A placebo-controlled dobule-blind study
36. Exhaustive physical excise causes oxidation of glutathione status in blood: Prevention by antioxidant administration